ORG 9487 Neuromuscular Block at the Adductor Pollicis and the Laryngeal Adductor Muscles in Humans
- 1 June 1997
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 86 (6) , 1300-1305
- https://doi.org/10.1097/00000542-199706000-00011
Abstract
Background: ORG 9487 is a new steroidal nondepolarizing muscle relaxant with a rapid onset of action. This study was designed to determine the neuromuscular blocking profile of ORG 9487 at the adductor muscles of the larynx and the adductor pollicis. Methods: In 30 adults, anesthesia was induced with propofol (2-5 mg/kg) and fentanyl (2-3 microg/kg). After train-of-four stimulation, the block of the laryngeal adductor muscles was evaluated by measuring the pressure changes in the cuff of the tracheal tube placed between the vocal cords, and the force of the contraction of the adductor pollicis was measured with a force transducer. Patients were randomly allocated to receive ORG 9487 at intravenous bolus doses of 0.75, 1.5 or 2 mg/kg (n = 10 in each group). Results: Time to peak effect was significantly shorter at the vocal cords than at the adductor pollicis muscle (P < 0.001). Onset time at the vocal cords was 62 +/- 16 s, 62 +/- 13 s, and 52 +/- 14 s (mean +/- SD) after doses of 0.75, 1.5, and 2 mg/kg, respectively (not significant). Onset time at the adductor pollicis muscle was 126 +/- 33 s, 96 +/- 20 s, and 82 +/- 21 s after 0.75, 1.5, and 2 mg/kg doses, respectively (P < 0.001). Maximum block was significantly less intense at the vocal cords than at the adductor pollicis muscle (69 +/- 15% vs. 94 +/- 4% after 0.75 mg/kg; 86 +/- 7% vs. 97 +/- 4% after 1.5 mg/kg; and 91 +/- 5% vs. 99 +/- 1% after 2 mg/kg). After 1.5 mg/kg duration to 25%, recovery was 3.7 +/- 2.2 min versus 10.2 +/- 2.5 min at the vocal cords and the adductor pollicis muscle, respectively, and 75% recovery occurred at 9.7 +/- 3.7 min at the vocal cords and at 18.3 +/- 5.2 min at the adductor pollicis muscle. Conclusions: ORG 9487 has a rapid onset of action at the laryngeal adductor and the adductor pollicis muscles. Onset and duration of action are faster at the vocal cords than at the adductor pollicis muscle. However, the maximum block obtained at the laryngeal muscles was less than at the adductor pollicis, regardless of the dose of ORG 9487.Keywords
This publication has 16 references indexed in Scilit:
- Mivacurium Neuromuscular Block at the Adductor Muscles of the Larynx and Adductor Pollicis in HumansAnesthesiology, 1996
- Good Clinical Research Practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agentsActa Anaesthesiologica Scandinavica, 1996
- Preliminary investigations of the clinical pharmacology of three short-acting non-depolarizing neuromuscular blocking agents, Org 9453, Org 9489 and Org 9487Canadian Journal of Anesthesia/Journal canadien d'anesthésie, 1994
- Time Course of Action and Endotracheal Intubating Conditions of Org 9487, a New Short-Acting Steroidal Muscle Relaxant; A Comparison with SuccinylcholineAnesthesia & Analgesia, 1993
- Rocuronium (ORG 9426) neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis in humansCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1992
- Neuromuscular Effects of Succinylcholine on the Vocal Cords and Adductor Pollicis MusclesAnesthesia & Analgesia, 1991
- Vecuronium Neuromuscular Blockade at the Adductor Muscles of the Larynx and Adductor PollicisAnesthesiology, 1991
- A Method to Measure Elicited Contraction of Laryngeal Adductor Muscles during AnesthesiaAnesthesiology, 1991
- A clinical sign to predict difficult tracheal intubation; a prospective studyCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1985
- Potency Determination for Vecuronium (ORG NC45)Anesthesiology, 1982